Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; Bumps FY Outlook Higher
Get Alerts ZBH Hot Sheet
Join SI Premium – FREE
Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.58, $0.02 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2022 EPS of $6.80-$6.90, versus prior of $6.70-6.90 and the consensus of $6.79. Sees sales 0-1%, versus (1%)-1%.
For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Avangrid (AGR) Tops Q1 EPS by 19c
- Chubb Corp. (CB) Tops Q1 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!